Skip to content

vNOTES Salpingo-oophorectomy or Bilateral Salpingectomy Compared With Laparoscopic.

Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) Salpingo-oophorectomy or Bilateral Salpingectomy Compared With Laparoscopic Approach. Prospective Study-A New Approach.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05228938
Enrollment
1
Registered
2022-02-08
Start date
2022-05-29
Completion date
2023-12-31
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Salpingectomy

Keywords

VNOTES, laparoscopic, Salpingo-oophorectomy, salpingectomy

Brief summary

Objective: To compare the vNOTES approach versus conventional laparoscopic approach used in elective Salpingo-oophorectomy surgery for benign disease or bilateral salpingectomy for sterilization. Study design: Prospective cohort, randomized controlled trial. Study population: Planned Salpingo-oophorectomy for benign disease or bilateral salpingectomy for sterilization. Primary outcome - Adherence to planned surgical route, intra-operative parameters & complications, post-operative parameters & complications, rate of satisfaction.

Detailed description

Objective: To compare the vNOTES approach versus conventional laparoscopic approach used in elective Salpingo-oophorectomy surgery for benign disease or bilateral salpingectomy for sterilization. Study design: Prospective cohort, randomized controlled trial. Study population: women aged over 18 who are planned to elective Salpingo-oophorectomy for benign disease or bilateral salpingectomy for sterilization. Primary outcome - Removal of the ovaries and/or fallopian tubes according to the allocated technique, without conversion. Secondary outcome - Duration of the surgical procedure, Duration of hospital admission (after surgery), The need for analgesics, and pain Numerical Rating Scale score , Post operation infection (up to 4 weeks from surgery), Need for medical examination/treatment or appearance of surgical complication up to 4 weeks form surgery (using Clavin Dindo Class), Bleeding assessment during surgery, Dyspareunia assessment - up to 3 months from surgery, Patient satisfaction from the surgical procedure will be measured with Patient Global Impression of Improvement (PGI-I).

Interventions

PROCEDUREVNOTES

vaginal Natural Orifice Transluminal Endoscopic Surgery approach for Elective bilateral salpingectomy or Salpingo-oophorectomy

PROCEDURElaparoscopic

laparoscopic Surgery approach for Elective bilateral salpingectomy or Salpingo-oophorectomy

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Women aged between 18 and 80 years. 2. women who seek for definitive surgical sterilisation. 3. women who planed for Elective bilateral salpingectomy or Salpingo-oophorectomy for a non-malignant indication

Exclusion criteria

1. history of rectal surgery. 2. rectovaginal endometriosis 3. suspected malignancy 4. History of pelvic inflammatory disease. 5. active lower genital tract infection. 6. Virgo women 7. pregnancy 8. Failure to provide written informed consent prior to surgery

Design outcomes

Primary

MeasureTime frameDescription
Successful removal of the fallopian tubes or adnexa without a need to convert to another technique.IntraoperativeNumber of Participants With Removal of the ovaries and/or fallopian tubes according to the allocated technique.

Secondary

MeasureTime frameDescription
Duration of hospital admission after surgical interventionfrom time of admission up to time of discharge from hospitalBetween surgery and time of discharge - in days
Bleeding assessment during surgical interventionIntraoperativeEstimation by the major surgeon of the quantity of bleeding during surgery - in ml The amount of blood in the vacuum container in the end of the surgery
Post operation infectiondetected during the first six weeks of surgeryPostoperative infection defined by lower abdominal pain with fever \> 38°C and positive clinical signs or laboratory findings, detected during the first six weeks of surgery, as a dichotomous outcome
Postoperative pain scoresDuring the first seven days after the surgical interventionPostoperative pain scores, measured using a Visual Analogue Scale (VAS) twice daily (morning and evening) from day 1 till 7 selfreported by the participating women. VAS scores from 0 to 10 with 0 = no pain and 10= worst pain ever imaginable.
The use of analgetic drugs for postoperative painDuring the first week after the surgical interventionPostoperative pain defined by the total amount of analgesics used, as a continuous outcome.
Duration of surgical interventionIntraoperative(Between incision and closure) in minutes
Postoperative ComplicationsDuring the first six weeks after the surgical interventionPostoperative complications detected during the first 6 weeks of surgery, as a dichotomous outcome
Vaginal Pain During Sexual Intercourse at Three MonthsAt 3 months after the surgical interventionIncidence of vaginal dyspareunia recorded by the participants at 3 months by self-reporting using a simple questionnaire, as a dichotomous outcome
Patient satisfaction from the surgical procedureAt 3 months after the surgical interventionrate of satisfacation estimated with Patient Global Impression of Improvement questionnaire (PGI-I) . (score 1-7)
Hospital ReadmissionDuring the first six weeks after the surgical interventionThe number of women readmitted to hospital within six weeks following surgery, as a dichotomous outcome.
Intra- Operative ComplicationsIntraoperativeIntra- operative complications according to the Clavien- Dindo classification detected during the first six weeks of surgery, as a dichotomous outcome

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026